デフォルト表紙
市場調査レポート
商品コード
1004582

呼吸器診断:世界市場規模予測(2020年~2028年)

Respiratory Diagnostics - Global Market Outlook (2020 -2028)

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 150+ Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.03円
呼吸器診断:世界市場規模予測(2020年~2028年)
出版日: 2021年04月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 150+ Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の呼吸器診断の市場規模は、2020年に69億4,000万米ドルとなり、予測期間中に9.3%のCAGRで成長し、2028年までに141億4,000万米ドルに達すると予測されています。

呼吸器疾患の有病率の上昇と技術の進歩は、市場の成長を推進する主な要因です。ただし、償還の懸念は市場の成長を妨げています。

当レポートでは呼吸器診断の世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、Covid-19の影響、テストタイプ・製品およびサービス・疾患・流通チャネル・エンドユーザー・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

  • イントロダクション
  • 促進要因
  • 抑制要因
  • 市場機会
  • 脅威
  • 製品分析
  • エンドユーザー分析
  • 新興市場
  • Covid-19の影響

第4章 ポーターズのファイブフォース分析

第5章 テストタイプ別

  • イントロダクション
  • 画像検査
    • コンピュータ断層撮影
    • 磁気共鳴画像法(MRI)
    • 陽電子放出断層撮影(PET)
    • X線
  • 機械的試験
    • 呼吸機能検査
    • ピークフローテスト
    • 閉塞性睡眠時無呼吸(OSA)診断テスト
  • 分子診断テスト
    • 核酸増幅検査
    • インサイチュハイブリダイゼーション
    • DNAシーケンシングと次世代シーケンシング(NGS)
    • マイクロアレイ
    • ポリメラーゼ連鎖反応(PCR)
  • 従来の診断テスト
    • 生化学的特性
    • 顕微鏡検査
    • 免疫診断

第6章 製品およびサービス別

  • イントロダクション
  • アッセイおよびキット/試薬
  • 機器とデバイス
    • テーブルトップ
    • スタンドアロン
    • ポータブル
  • サービスとソフトウェア

第7章 疾患別

  • イントロダクション
  • 喘息
  • 慢性閉塞性肺疾患(COPD)
  • 肺癌
  • 結核
  • その他の病気
    • 気管支炎
    • 肺線維症
    • 呼吸器感染

第8章 流通チャネル別

  • イントロダクション
  • 小売販売
  • 直接入札

第9章 エンドユーザー別

  • イントロダクション
  • 病院/臨床検査室
  • 医師のオフィス
  • リファレンスラボラトリーズ
  • クリニック
  • その他のエンドユーザー
    • 血液銀行
    • ポイントオブケア検査
    • 患者の自己診断

第10章 地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東およびアフリカ

第11章 主な発展

  • 契約、パートナーシップ、コラボレーション、ジョイントベンチャー
  • 買収と合併
  • 新製品の発売
  • 拡張
  • その他の重要な戦略

第12章 企業プロファイル

  • Abbott Diagnostics Inc.
  • Becton, Dickinson and Company
  • CAREstream Medical Ltd.
  • Fisher & Paykel Healthcare, Inc.
  • GE Healthcare Limited
  • Koninklijke Philips N.V
  • Medtronic, Inc.
  • MGC Diagnostics Corporation
  • ResMed Inc.
  • Thermo Fisher Scientific Inc.
  • 3M
  • Philips Healthcare
  • Biomerieux
  • COSMED
  • Bio-Rad Laboratories Inc.
  • SDI Diagnostics
  • Seegene Inc.
  • Alere Inc.
図表

List of Tables

  • Table 1 Global Respiratory Diagnostics Market Outlook, By Region (2019-2028) ($MN)
  • Table 2 Global Respiratory Diagnostics Market Outlook, By Test Type (2019-2028) ($MN)
  • Table 3 Global Respiratory Diagnostics Market Outlook, By Imaging Tests (2019-2028) ($MN)
  • Table 4 Global Respiratory Diagnostics Market Outlook, By Computed Tomography (2019-2028) ($MN)
  • Table 5 Global Respiratory Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) (2019-2028) ($MN)
  • Table 6 Global Respiratory Diagnostics Market Outlook, By Positron Emission Tomography (PET) (2019-2028) ($MN)
  • Table 7 Global Respiratory Diagnostics Market Outlook, By X-Ray (2019-2028) ($MN)
  • Table 8 Global Respiratory Diagnostics Market Outlook, By Mechanical Tests (2019-2028) ($MN)
  • Table 9 Global Respiratory Diagnostics Market Outlook, By Pulmonary Function Tests (2019-2028) ($MN)
  • Table 10 Global Respiratory Diagnostics Market Outlook, By Peak Flow Test (2019-2028) ($MN)
  • Table 11 Global Respiratory Diagnostics Market Outlook, By Obstructive Sleep Apnoea (OSA) Diagnostic Tests (2019-2028) ($MN)
  • Table 12 Global Respiratory Diagnostics Market Outlook, By Molecular Diagnostic Tests (2019-2028) ($MN)
  • Table 13 Global Respiratory Diagnostics Market Outlook, By Nucleic Acid Amplification Test (2019-2028) ($MN)
  • Table 14 Global Respiratory Diagnostics Market Outlook, By In Situ Hybridization (2019-2028) ($MN)
  • Table 15 Global Respiratory Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (NGS) (2019-2028) ($MN)
  • Table 16 Global Respiratory Diagnostics Market Outlook, By Microarrays (2019-2028) ($MN)
  • Table 17 Global Respiratory Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2019-2028) ($MN)
  • Table 18 Global Respiratory Diagnostics Market Outlook, By Traditional Diagnostic Tests (2019-2028) ($MN)
  • Table 19 Global Respiratory Diagnostics Market Outlook, By Biochemical Characterization (2019-2028) ($MN)
  • Table 20 Global Respiratory Diagnostics Market Outlook, By Microscopy (2019-2028) ($MN)
  • Table 21 Global Respiratory Diagnostics Market Outlook, By Immunodiagnostics (2019-2028) ($MN)
  • Table 22 Global Respiratory Diagnostics Market Outlook, By Product and Service (2019-2028) ($MN)
  • Table 23 Global Respiratory Diagnostics Market Outlook, By Assays and Kits/Reagents (2019-2028) ($MN)
  • Table 24 Global Respiratory Diagnostics Market Outlook, By Instruments and Devices (2019-2028) ($MN)
  • Table 25 Global Respiratory Diagnostics Market Outlook, By Tabletop (2019-2028) ($MN)
  • Table 26 Global Respiratory Diagnostics Market Outlook, By Standalone (2019-2028) ($MN)
  • Table 27 Global Respiratory Diagnostics Market Outlook, By Portable (2019-2028) ($MN)
  • Table 28 Global Respiratory Diagnostics Market Outlook, By Services and Software (2019-2028) ($MN)
  • Table 29 Global Respiratory Diagnostics Market Outlook, By Disease (2019-2028) ($MN)
  • Table 30 Global Respiratory Diagnostics Market Outlook, By Asthma (2019-2028) ($MN)
  • Table 31 Global Respiratory Diagnostics Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2019-2028) ($MN)
  • Table 32 Global Respiratory Diagnostics Market Outlook, By Lung Cancer (2019-2028) ($MN)
  • Table 33 Global Respiratory Diagnostics Market Outlook, By Tuberculosis (2019-2028) ($MN)
  • Table 34 Global Respiratory Diagnostics Market Outlook, By Other Diseases (2019-2028) ($MN)
  • Table 35 Global Respiratory Diagnostics Market Outlook, By Bronchitis (2019-2028) ($MN)
  • Table 36 Global Respiratory Diagnostics Market Outlook, By Pulmonary Fibrosis (2019-2028) ($MN)
  • Table 37 Global Respiratory Diagnostics Market Outlook, By Respiratory Infection (2019-2028) ($MN)
  • Table 38 Global Respiratory Diagnostics Market Outlook, By Distribution Channel (2019-2028) ($MN)
  • Table 39 Global Respiratory Diagnostics Market Outlook, By Retail Sales (2019-2028) ($MN)
  • Table 40 Global Respiratory Diagnostics Market Outlook, By Direct Tender (2019-2028) ($MN)
  • Table 41 Global Respiratory Diagnostics Market Outlook, By End User (2019-2028) ($MN)
  • Table 42 Global Respiratory Diagnostics Market Outlook, By Hospital/Clinical Laboratories (2019-2028) ($MN)
  • Table 43 Global Respiratory Diagnostics Market Outlook, By Physician Offices (2019-2028) ($MN)
  • Table 44 Global Respiratory Diagnostics Market Outlook, By Reference Laboratories (2019-2028) ($MN)
  • Table 45 Global Respiratory Diagnostics Market Outlook, By Clinics (2019-2028) ($MN)
  • Table 46 Global Respiratory Diagnostics Market Outlook, By Other End Users (2019-2028) ($MN)
  • Table 47 Global Respiratory Diagnostics Market Outlook, By Blood Banks (2019-2028) ($MN)
  • Table 48 Global Respiratory Diagnostics Market Outlook, By Point-Of-Care Testing (2019-2028) ($MN)
  • Table 49 Global Respiratory Diagnostics Market Outlook, By Patient Self-Testing (2019-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

目次

According to Stratistics MRC, the Global Respiratory Diagnostics Market is accounted for $6.94 billion in 2020 and is expected to reach $14.14 billion by 2028 growing at a CAGR of 9.3% during the forecast period. The rising prevalence of respiratory diseases and technological advancements are the major factors propelling market growth. However, reimbursement concerns are hampering market growth.

Respiratory diagnostics have a principal part in the therapeutic innovation area. It involves the clinical assessment of some kinds of respiratory conditions such as bronchitis, asthma, COPD, pulmonary fibrosis among others by using various kinds of mechanical, imaging, and molecular diagnostics tests.

Based on the test type, the traditional diagnostic tests segment is estimated to have a lucrative growth due to it is widely used by developing countries and the fast working time of these tests allows patients to get effective results in a shorter period which further improves treatment procedures.

By geography, North America is going to have a lucrative growth during the forecast period due to the increasing prevalence of respiratory diseases and the growing anti-aging population. The U.S. dominates North America's respiratory diagnostics market due to its advanced healthcare system and strong distribution channels.

Some of the key players profiled in the Respiratory Diagnostics Market include Abbott Diagnostics Inc., Becton, Dickinson and Company, CAREstream Medical Ltd., Fisher & Paykel Healthcare, Inc., GE Healthcare Limited, Koninklijke Philips N.V, Medtronic, Inc., MGC Diagnostics Corporation, ResMed Inc., Thermo Fisher Scientific Inc., 3M, Philips Healthcare, Biomerieux, COSMED, Bio-Rad Laboratories Inc., SDI Diagnostics, Seegene Inc., and Alere Inc.

Test Types Covered:

  • Imaging Tests
  • Mechanical Tests
  • Molecular Diagnostic Tests
  • Traditional Diagnostic Tests

Product and Services Covered:

  • Assays and Kits/Reagents
  • Instruments and Devices
  • Services and Software

Diseases Covered:

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Lung Cancer
  • Tuberculosis
  • Other Diseases

Distribution Channels Covered:

  • Retail Sales
  • Direct Tender

End Users Covered:

  • Hospital/Clinical Laboratories
  • Physician Offices
  • Reference Laboratories
  • Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Respiratory Diagnostics Market, By Test Type

  • 5.1 Introduction
  • 5.2 Imaging Tests
    • 5.2.1 Computed Tomography
    • 5.2.2 Magnetic Resonance Imaging (MRI)
    • 5.2.3 Positron Emission Tomography (PET)
    • 5.2.4 X-Ray
  • 5.3 Mechanical Tests
    • 5.3.1 Pulmonary Function Tests
      • 5.3.1.1 Spirometry
      • 5.3.1.2 Diffusion Capacity Test
      • 5.3.1.3 Plethysmography Test
    • 5.3.2 Peak Flow Test
    • 5.3.3 Obstructive Sleep Apnoea (OSA) Diagnostic Tests
      • 5.3.3.1 Polysomnography
      • 5.3.3.2 Home Sleep Apnea Testing
  • 5.4 Molecular Diagnostic Tests
    • 5.4.1 Nucleic Acid Amplification Test
    • 5.4.2 In Situ Hybridization
    • 5.4.3 DNA Sequencing & Next-Generation Sequencing (NGS)
    • 5.4.4 Microarrays
    • 5.4.5 Polymerase Chain Reaction (PCR)
  • 5.5 Traditional Diagnostic Tests
    • 5.5.1 Biochemical Characterization
    • 5.5.2 Microscopy
    • 5.5.3 Immunodiagnostics

6 Global Respiratory Diagnostics Market, By Product and Service

  • 6.1 Introduction
  • 6.2 Assays and Kits/Reagents
  • 6.3 Instruments and Devices
    • 6.3.1 Tabletop
    • 6.3.2 Standalone
    • 6.3.3 Portable
  • 6.4 Services and Software

7 Global Respiratory Diagnostics Market, By Disease

  • 7.1 Introduction
  • 7.2 Asthma
  • 7.3 Chronic Obstructive Pulmonary Disease (COPD)
  • 7.4 Lung Cancer
  • 7.5 Tuberculosis
  • 7.6 Other Diseases
    • 7.6.1 Bronchitis
    • 7.6.2 Pulmonary Fibrosis
    • 7.6.3 Respiratory Infection

8 Global Respiratory Diagnostics Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Retail Sales
  • 8.3 Direct Tender

9 Global Respiratory Diagnostics Market, By End User

  • 9.1 Introduction
  • 9.2 Hospital/Clinical Laboratories
  • 9.3 Physician Offices
  • 9.4 Reference Laboratories
  • 9.5 Clinics
  • 9.6 Other End Users
    • 9.6.1 Blood Banks
    • 9.6.2 Point-Of-Care Testing
    • 9.6.3 Patient Self-Testing

10 Global Respiratory Diagnostics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Diagnostics Inc.
  • 12.2 Becton, Dickinson and Company
  • 12.3 CAREstream Medical Ltd.
  • 12.4 Fisher & Paykel Healthcare, Inc.
  • 12.5 GE Healthcare Limited
  • 12.6 Koninklijke Philips N.V
  • 12.7 Medtronic, Inc.
  • 12.8 MGC Diagnostics Corporation
  • 12.9 ResMed Inc.
  • 12.10 Thermo Fisher Scientific Inc.
  • 12.11 3M
  • 12.12 Philips Healthcare
  • 12.13 Biomerieux
  • 12.14 COSMED
  • 12.15 Bio-Rad Laboratories Inc.
  • 12.16 SDI Diagnostics
  • 12.17 Seegene Inc.
  • 12.18 Alere Inc.